Glipizide and Metformin HCl NDC 71205-270

NDC codes

FDA NDC Directory

Product NDC (as listed)71205-270Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71205-0270Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71205-270-30	71205027030	30 TABLET, FILM COATED in 1 BOTTLE (71205-270-30)Marketed from May 1, 2019
71205-270-60	71205027060	60 TABLET, FILM COATED in 1 BOTTLE (71205-270-60)Marketed from May 1, 2019
71205-270-90	71205027090	90 TABLET, FILM COATED in 1 BOTTLE (71205-270-90)Marketed from May 1, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Glipizide and Metformin HCl
Generic name (nonproprietary): glipizide and metformin hcl
Active ingredients: Glipizide — 5 mg/1Metformin hydrochloride — 500 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078728
Marketing start: Jun 29, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Biguanides (Chemical structure)Sulfonylurea Compounds (Chemical structure)
Identifiers: Product ID 71205-270_ba23a55b-30dd-4d55-a423-3542524a8efeSPL ID ba23a55b-30dd-4d55-a423-3542524a8efeSPL set ID be4d2552-c964-4d09-ba7a-0d94320f968cRxCUI 861740UNII X7WDT95N5C, 786Z46389E
Pharmacologic class: Biguanide; Sulfonylurea

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205027030 followed by a unit qualifier and the quantity

Package 71205-0270-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 1, 2019.

Indications (excerpt from the label)

INDICATIONS AND USAGE Glipizide and Metformin HCl Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 078728

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078728
Product	Strength	Form · route	Labeler	Product NDC
Glipizide and Metformin HCl	Glipizide 2.5 mg/1; Metformin hydrochloride 250 mg/1	Tablet, Film coatedOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-115
Glipizide and Metformin HCl	Glipizide 2.5 mg/1; Metformin hydrochloride 500 mg/1	Tablet, Film coatedOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-116
Glipizide and Metformin HCl	Glipizide 5 mg/1; Metformin hydrochloride 500 mg/1	Tablet, Film coatedOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-117
Glipizide and metformin hcl	Glipizide 2.5 mg/1; Metformin hydrochloride 250 mg/1	Tablet, Film coatedOral	Chartwell RX, LLC	62135-731
Glipizide and metformin hcl	Glipizide 2.5 mg/1; Metformin hydrochloride 500 mg/1	Tablet, Film coatedOral	Chartwell RX, LLC	62135-732
Glipizide and metformin hcl	Glipizide 5 mg/1; Metformin hydrochloride 500 mg/1	Tablet, Film coatedOral	Chartwell RX, LLC	62135-733